1970 Fiat 500 on 2040-cars

Auto blog

Fiat Chrysler says it did not know about Marchionne's illness

ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.

Chrysler IPO to be filed as early as this week

An initial public offering for the Chrysler Group could happen this week, following Sergio Marchionne's comments to Financial Times in London, according to a report from The Detroit News. Fiat, which owns 58.5 percent of Chrysler, has been in a battle with the UAW retiree healthcare trust over its minority stake in the company. While the automotive union recognizes its role as a temporary shareholder, the two couldn't come to an agreement on how the shares should be priced.
As Marchionne explained to FT, a Chrysler IPO allows the market, rather than the two competing sides, to determine the value of the shares. The public offering is a risky move, which could potentially hang one side out to dry - if the shares go high, it's bad news for Fiat, but if they go low, the UAW stands to lose. Regardless of where the stock prices go in an IPO, though, it's a move that's being supported by analysts, who are quick to cite Chrysler's near-constant growth and a product lineup that is getting healthier with each new introduction.

The Fiat 124 Spider's future is uncertain

Earlier this month, Fiat brand CEO Olivier Francois explained to Autocar that Fiat would re-focus on “the right balance between the two dimensions: the Fiat 500 family and family transportation. There will be no big cars, no premium cars, no sporty cars because they have no legitimacy. We will be present in the C-segment [Ford Focus class] but not much more. All models will sit within 3.5m and 4.5m (11.5 to 14.8 feet). This is where Fiat will play. We need more EVs. And we need more 500 models that look legitimate enough to take higher pricing.” Francois didn't say the 124 Spider is doomed, but Autocar understands that a second generation of the Mazda MX-5/Miata-based roadster is "unlikely." The comments on the 124 Spider come in the wake of Fiat pulling the droptop from the UK market because the car wasn't making money. The CEO said the partnership that created the convertible made sense, yet that while the 124 is profitable overall, "such a car may not be key to the future of the brand. It is not what IÂ’d call a pure, absolute Fiat, but for now, it remains an interesting opportunity.” The 124 Spider costs a touch less than the MX-5/Miata in the U.S., the opposite of UK pricing; nevertheless, the Mazda handily outsells the Italian after three years on sale. If Mazda keeps the fourth generation Miata around for 10 years as it did with the third generation, though, there could be a few years left to enjoy the 124 Spider even in the face of declining sales. The future of the Fiat brand in Europe will be built on the 500 on the next Panda city cars, joined by "a range of larger vehicles suitable for families;" one-third of the city cars sold in Europe are Fiats. The brand's U.S. lineup, aside from Abarths, is four 500-based cars and the 124 Spider. The 500 range will go upscale in order to justify higher prices to pay for electrified 500 and Panda platforms. A new electric 500 is expected next year, Francois describing that car in March as, "A new 500, totally renewed. A new object. Totally electric. It's kind of an urban Tesla, with beautiful style.